journal
https://read.qxmd.com/read/38358335/cannabidiol-exposure-during-gestation-leads-to-adverse-cardiac-outcomes-early-in-postnatal-life-in-male-rat-offspring
#21
JOURNAL ARTICLE
Kendrick Lee, Sebastian Vanin, Mina Nashed, Mohammed Halit Sarikahya, Steven R Laviolette, David R C Natale, Daniel B Hardy
Introduction: Studies indicate that ∼7% of pregnant individuals in North America consume cannabis in pregnancy. Pre-clinical studies have established that maternal exposure to Δ9 -tetrahydrocannabinol (THC; major psychoactive component in cannabis) leads to fetal growth restriction and impaired cardiac function in offspring. However, the effects of maternal exposure to cannabidiol (CBD; major non-euphoric constituent) on cardiac outcomes in offspring remain unknown. Therefore, our objective is to investigate the functional and underlying molecular impacts in the hearts of offspring exposed to CBD in pregnancy...
February 14, 2024: Cannabis and Cannabinoid Research
https://read.qxmd.com/read/38335314/cannabis-use-and-biomarkers-of-inflammation-immune-activation-and-microbial-translocation-in-persons-with-hiv
#22
JOURNAL ARTICLE
Chukwuemeka N Okafor, Anoma Somasunderam, Jordan E Lake, Jonathan Gelfond, Marjan Javanbakht, Pamina Gorbach, Steven Shoptaw, Joy Schmitz
Background: The relationship between cannabis and inflammation among persons with HIV (PWH) remains unclear. We examined whether the cannabis metabolite 11-nor-9-carboxy THC (THC-COOH) is associated with lower levels of plasma biomarkers of inflammation, immune activation, and microbial translocation in PWH. We hypothesized that cannabis use would be associated with lower levels of plasma inflammatory biomarkers than noncannabis use. Methods: We quantified THC-COOH in plasma, with THC-COOH levels between 5...
February 9, 2024: Cannabis and Cannabinoid Research
https://read.qxmd.com/read/38294845/comparison-between-smoked-tobacco-and-medical-cannabis-cigarettes-concerning-particulate-matter
#23
JOURNAL ARTICLE
Fenna Janssen, Markus Braun, Janis Dröge, Dörthe Brüggmann, David A Groneberg
Introduction: Cannabis is a widely used drug like tobacco and alcohol. In the meantime, it is also prescribed for medical treatment in some countries. Tobacco smoke contains chemical carcinogens and particulate matter (PM) that are both harmful to health. Method: In this study, we investigated PM levels in second-hand smoke (SHS) of hand-tamped cannabis cigarettes compared to cigarettes with tubing tobacco and the 3R4F reference cigarette. Results: It could be demonstrated that the largest proportion of the particle mass is attributable to particles with a diameter of less than 1μm and that every tested cigarette emitted more PM than the 3R4F reference cigarette...
January 31, 2024: Cannabis and Cannabinoid Research
https://read.qxmd.com/read/38363823/acknowledgment-of-reviewers-2023
#24
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
February 2024: Cannabis and Cannabinoid Research
https://read.qxmd.com/read/35881851/the-effects-of-cannabidiol-and-%C3%AE-9-tetrahydrocannabinol-in-social-cognition-a-naturalistic-controlled-study
#25
RANDOMIZED CONTROLLED TRIAL
Alberto Sainz-Cort, Daniel Jimenez-Garrido, Elena Muñoz-Marron, Raquel Viejo-Sobera, Joost Heeroma, Jose Carlos Bouso
Background: Social cognition abilities such as empathy and the Theory of Mind (ToM) have been shown to be impaired in neuropsychiatric conditions such as psychotic, autistic, and bipolar disorders. The endocannabinoid system (ECS) seems to play a role in social behavior and emotional processing while it also seems to play a role in those neuropsychiatric conditions showing social cognition impairments. Main plant cannabinoids delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) modulate the ECS and, due to their opposite effects, have been proposed as both cause and treatment for neuropsychiatric-related disorders such as schizophrenia, anxiety, or post-traumatic stress disorder (PTSD)...
February 2024: Cannabis and Cannabinoid Research
https://read.qxmd.com/read/38265773/astrocytic-dagla-deletion-decreases-hedonic-feeding-in-female-mice
#26
JOURNAL ARTICLE
Este Leidmaa, Alexandra Maria Prodan, Lena-Louise Depner, Joanna Agnieszka Komorowska-Müller, Eva Carolina Beins, Britta Schuermann, Carl-Christian Kolbe, Andreas Zimmer
Introduction: Endocannabinoids and exogenous cannabinoids are potent regulators of feeding behavior and energy metabolism. Stimulating cannabinoid receptor signaling enhances appetite, particularly for energy-dense palatable foods, and promotes energy storage. To elucidate the underlying cellular mechanisms, we investigate here the potential role of astrocytic endocannabinoid 2-arachidonoylglycerol (2-AG). Astrocytes provide metabolic support for neurons and contribute to feeding regulation but the effect of astrocytic 2-AG on feeding is unknown...
January 24, 2024: Cannabis and Cannabinoid Research
https://read.qxmd.com/read/38265476/the-effect-of-nabiximols-on-driving-ability-in-adults-with-chronic-tic-disorders-results-of-a-substudy-analysis-of-the-double-blind-randomized-placebo-controlled-canna-tics-trial
#27
JOURNAL ARTICLE
Kirsten R Müller-Vahl, Anna Pisarenko, Rieke Ringlstetter, Camelia-Lucia Cimpianu, Carolin Fremer, Elif Weidinger, Eva Beate Jenz, Richard Musil, Alexander Brunnauer, Anika Großhennig
Background: The multicenter, randomized, double-blind, parallel-group, phase IIIb CANNA-TICS (CANNAbinoids in the treatment of TICS) trial showed clear trends for improvement of tics, depression, and quality of life with nabiximols versus placebo in adult patients with Gilles de la Tourette syndrome and other chronic tic disorders. Although in general nabiximols was well tolerated, it is unclear whether treatment using this cannabis extract influences driving skills in patients with chronic tic disorders. Methods: Here we report results of the "Fitness to Drive" substudy of the CANNA-TICS trial...
January 23, 2024: Cannabis and Cannabinoid Research
https://read.qxmd.com/read/38502778/electrophysiological-phenotypes-of-hippocampal-synaptic-and-network-functions-in-cannabinoid-receptor-2-knockout-mice
#28
JOURNAL ARTICLE
Shuangtao Li, Yongchang He, Dharshaun Turner, Naili Wei, Luyao Ma, Devin H Taylor, Danielle T Taylor, Xiaoyu Ji, Jie Wu
Background: The cannabinoid receptor 2 (CB2R), a cannabinoid receptor primarily expressed in immune cells, has been found in the brain, particularly in the hippocampus, where it plays crucial roles in modulating various neural functions, including synaptic plasticity, neuroprotection, neurogenesis, anxiety and stress responses, and neuroinflammation. Despite this growing understanding, the intricate electrophysiological characteristics of hippocampal neurons in CB2R knockout (CB2R KO) mice remain elusive. Aim and Methods: This study aimed to comprehensively assess the electrophysiological traits of hippocampal synaptic and network functions in CB2R KO mice...
January 22, 2024: Cannabis and Cannabinoid Research
https://read.qxmd.com/read/38252549/oral-cannabidiol-treatment-is-associated-with-an-anti-inflammatory-gene-expression-signature-in-myeloid-cells-of-people-living-with-hiv
#29
JOURNAL ARTICLE
Simone Marini, Amanda Huber, Melanie N Cash, Marco Salemi, Robert L Cook, Paul Borsa, Carla N Mavian
Introduction: HIV-related comorbidities appear to be related to chronic inflammation, a condition characterizing people living with HIV (PLWH). Prior work indicates that cannabidiol (CBD) might reduce inflammation; however, the genetics underpinning of this effect are not well investigated. Our main objective is to detect gene expression alterations in human peripheral blood mononuclear cells (PBMCs) from PLWH after at least 1 month of CBD treatment. Materials and Methods: We analyzed ∼41,000 PBMCs from three PLWH at baseline and after CBD treatment (27-60 days) through single-cell RNA sequencing...
January 22, 2024: Cannabis and Cannabinoid Research
https://read.qxmd.com/read/38252548/antimicrobial-effect-of-cannabidiol-on-intracellular-mycobacterium-tuberculosis
#30
JOURNAL ARTICLE
Camila Belen Martinena, Merlina Corleto, Melina María Belén Martínez, Nicolás Oscar Amiano, Verónica Edith García, Paulo Cesar Maffia, Nancy Liliana Tateosian
Introduction: Mycobacterium tuberculosis , the etiologic agent of tuberculosis (TB), has killed nearly one billion people during the last two centuries. Nowadays, TB remains a major global health problem ranked among the top 10 causes of death worldwide. One of the main challenges in developing new strategies to fight TB is focused on reducing the duration and complexity of drug regimens. Cannabidiol (CBD) is the main nonpsychoactive ingredient extracted from the Cannabis sativa L . plant, which has been shown to be biologically active against bacteria...
January 22, 2024: Cannabis and Cannabinoid Research
https://read.qxmd.com/read/38252547/acute-and-extended-anxiolytic-effects-of-cannabidiol-in-cannabis-flower-a-quasi-experimental-ad-libitum-use-study
#31
JOURNAL ARTICLE
L Cinnamon Bidwell, Renée Martin-Willett, Carillon Skrzynski, Jonathon Lisano, Marco Ortiz Torres, Gregory Giordano, Kent E Hutchison, Angela D Bryan
Objective: Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) have varying pharmacological actions with differential effects on acute and extended affective states, incuding anxiety. We aimed to study these effects on anxiety in legal market forms of cannabis. Method: This study makes use of a nonequivalent control group quasiexperimental design. Forty-two participants with anxiety symptions who were not using cannabis were compared to 258 participants with anxiety symptoms who used cannabis flower (∼3-4 times per week)...
January 22, 2024: Cannabis and Cannabinoid Research
https://read.qxmd.com/read/38252502/cannabis-roots-therapeutic-biotechnological-and-environmental-aspects
#32
JOURNAL ARTICLE
Valérie Gagné, Nathalie Boucher, Isabel Desgagné-Penix
Since the legalization of recreational cannabis in Canada in 2018, the number of licenses for this crop has increased significantly, resulting in an increase in waste generated. Nevertheless, cannabis roots were once used for their therapeutic properties, indicating that they could be valued today rather than dismissed. This review will focus on both traditional therapeutic aspects and potential use of roots in modern medicine while detailing the main studies on active phytomolecules found in cannabis roots...
January 22, 2024: Cannabis and Cannabinoid Research
https://read.qxmd.com/read/38252501/bibliometric-analysis-of-cannabis-sativa-research-trends-challenges-and-future-directions
#33
JOURNAL ARTICLE
Brayan Jonas Mano-Sousa, Lucas Antônio Ribeiro Lisboa, Bruna Cristina Alves, Ana Clara Anacleto Gonçalves, Luiza Martins Silva, Joaquim Maurício Duarte-Almeida
Introduction: The use of medical Cannabis remains unregulated in several countries due to the scarcity of clinical studies with high scientific evidence that establish safety and efficacy of Cannabis products. This study aimed to comprehensively analyze how knowledge has been created in this field, as well as perform a bibliographic mapping to identify knowledge gaps, and investigate key authors and journals that have significantly contributed to advancing our understanding of Cannabis . Method: The study protocol was registered in the International Prospective Register of Systematic Review (CRD42020223084)...
January 19, 2024: Cannabis and Cannabinoid Research
https://read.qxmd.com/read/38237126/identification-and-optimization-of-more-efficient-olivetolic-acid-synthases
#34
JOURNAL ARTICLE
Yue Yang, Shimeng Liu, Zihe Li, Changlong Lai, Hao Wu, Zhenzhu Li, Wenhao Xia, Qiuhui Du, Lihui Huang, Wen Wang, Xiao Wang, Xianqing Chen
Introduction: Olivetolic acid (OLA) is a key intermediate in cannabidiol (CBD) synthesis, and cannabinoids are important neuroactive drugs. However, the catalytic activity of olivetolic acid synthase (OLS), the key enzyme involved in OLA biosynthesis, remains low and its catalytic mechanism is unclear. Materials and Methods: In this study, we conducted a scrupulous screening of the pivotal rate-limiting enzyme and analyzed its amino acid sites that are critical to enzyme activity as validated by experiments...
January 19, 2024: Cannabis and Cannabinoid Research
https://read.qxmd.com/read/38237125/types-and-brands-of-derived-psychoactive-cannabis-products-an-online-retail-assessment-2023
#35
JOURNAL ARTICLE
Matthew E Rossheim, Kayla K Tillett, Viktor Vasilev, Cassidy R LoParco, Carla J Berg, Pamela J Trangenstein, R Andrew Yockey, Steven Y Sussman, Michael Siegel, David H Jernigan
Background: The 2018 Farm Bill led to new types of derived psychoactive cannabis products (DPCPs) being sold throughout the United States. This study describes the new types and brands of DPCPs sold online. Materials and Methods: In May 2023, data were recorded from three top-trafficked U.S.-based DPCP retail websites, including information about each product ( N =804). Results: DPCP modalities included disposable vapes (43%), edibles (29%), vape carts (18%), pre-rolls (7%), flower (2%), dabs (1%), and vape pods (<1%)...
January 19, 2024: Cannabis and Cannabinoid Research
https://read.qxmd.com/read/38227785/-correction-to-chemistry-and-biological-activities-of-cannflavins-of-the-cannabis-plant-by-abdel-kader-et-al-cannabis-and-cannabinoid-research-2023-8-6-974-985-doi-10-1089-can-2023-0128
#36
(no author information available yet)
No abstract text is available yet for this article.
January 12, 2024: Cannabis and Cannabinoid Research
https://read.qxmd.com/read/38197849/prediction-and-discovery-of-cannabidiol-crystal-polymorph-form-2
#37
JOURNAL ARTICLE
Crist N Filer
The article puts into perspective the recent discovery of cannabidiol crystal polymorph Form 2.
January 10, 2024: Cannabis and Cannabinoid Research
https://read.qxmd.com/read/38190272/temporal-trends-in-semen-quality-hormone-levels-and-substance-use-among-infertile-men-in-pre-and-post-cannabis-legalization-eras-in-canada
#38
JOURNAL ARTICLE
Gilad Karavani, Adam Bobrowski, Katherine Lajkosz, Susan Lau, Kirk C Lo, Ethan D Grober, Yonah Krakowsky, Keith Jarvi
Background: The Cannabis Act (Bill C-45) was enacted in 2018, to legalize and regulate the use, production, and sale of nonmedical cannabis in Canada. While public health and safety implications of cannabis legalization have yet to be elucidated, the wide availability of cannabis necessitates health care providers to be knowledgeable about therapeutic potential and side effects of use. This study aimed to examine the temporal trends over two decades and the impact of the Cannabis Act in Canada, implemented in October 2018, on substance use, semen parameters, and testosterone levels of infertile men...
January 9, 2024: Cannabis and Cannabinoid Research
https://read.qxmd.com/read/38190273/sex-differences-in-response-contingent-cannabis-vapor-administration-during-adolescence-mediate-enduring-effects-on-behavioral-flexibility-and-prefrontal-microglia-activation-in-rats
#39
JOURNAL ARTICLE
Timothy G Freels, Sara R Westbrook, Erica Zamberletti, Jacqulyn R Kuyat, Hayden R Wright, Alexandra N Malena, Max W Melville, Amanda M Brown, Nicholas C Glodosky, Darren E Ginder, Courtney M Klappenbach, Kristen M Delevich, Tiziana Rubino, Ryan J McLaughlin
Introduction: Cannabis is the most used illicit drug in the United States. With many states passing legislation to permit its recreational use, there is concern that cannabis use among adolescents could increase dramatically in the coming years. Historically, it has been difficult to model real-world cannabis use to investigate the causal relationship between cannabis use in adolescence and behavioral and neurobiological effects in adulthood. Materials and Methods: We used a response-contingent vapor administration model to investigate long-term effects of cannabis use during adolescence on the medial prefrontal cortex (mPFC) and mPFC-dependent behaviors in male and female rats...
January 8, 2024: Cannabis and Cannabinoid Research
https://read.qxmd.com/read/38181167/cannabidiol-mediates-in-vitro-attenuation-of-proinflammatory-cytokine-responses-in-psoriatic-disease
#40
JOURNAL ARTICLE
Sotirios G Tsiogkas, Konstantina Apostolopoulou, Evangelia D Papagianni, Athanasios Mavropoulos, Efthimios Dardiotis, Efterpi Zafiriou, Dimitrios P Bogdanos
Background: Cannabidiol (CBD), a substance that belongs to the phytocannabinoids, appears to exert antioxidant, neuroprotective, antipsychotic, anticonvulsant, and anticancer properties. Recent evidence supports the immunoregulatory effect of CBD on autoimmune and/or inflammatory disease. Psoriasis is a chronic skin disease. The main immune cell population involved in the pathogenesis of the disease is the interleukin- (IL-) 17-producing T helper (Th) 17 subset. Other subpopulations, such as interferon-γ (IFNγ) -producing Th1 and T cytotoxic (Tc) 1, IL-17-producing Tc17, as well as natural killer (NK) and natural killer T cells (NKT) have been implicated in psoriasis development...
January 5, 2024: Cannabis and Cannabinoid Research
journal
journal
53424
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.